Balanced news tone
News Sentiment
BCT sentiment intelligence
BriaCell Therapeutics Corp. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
45
Balanced news tone
15 relevant articles
Price is moving more forcefully than the current news tone suggests.
93/100 classification confidence.
directly relevant articles
high-authority source matches
+8.2% over one week, -14.2% over four weeks, trend inactive, and below fair value.
Briacell Therapeutics Corp (BCTX) Risk Assessment: Volatility, Financial Risk & Investment Risk
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
93/100 classification
One-week reaction
8.2%
Price confirming higher
Trend fit
Trend inactive
-14.2% over four weeks
Fair value
-98.8%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
0
Neutral
13
Negative
2
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
TradingKey
Direct company coverage
Briacell Therapeutics Corp (BCTX) Risk Assessment: Volatility, Financial Risk & Investment Risk
- Tone
- Negative 5/100
- Event
- Market update
- Published
- 18 Jun 2026 02:28
- Source
- TradingKey
Wealth Awesome
Direct company coverage
Why Briacell Therapeutics Corp stock is tanking today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 02:01
- Source
- Wealth Awesome
Wealth Awesome
Direct company coverage
Why Briacell Therapeutics Corp stock is rising today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 14:55
- Source
- Wealth Awesome
The Globe and Mail
Direct company coverage
BriaCell Therapeutics Completes Equity Offering to Fund Operations
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- The Globe and Mail
Stock Titan
Direct company coverage
BriaCell (NASDAQ: BCTX) completes $4.71M best efforts common share sale
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- Stock Titan
marketscreener.com
Direct company coverage
BriaCell Presenting Final Phase 2, Ongoing Phase 3 Data at ASCO Meeting
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- marketscreener.com
TradingView
Direct company coverage
Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 May 2026 07:00
- Source
- TradingView
GlobeNewswire
Direct company coverage
BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 07:00
- Source
- GlobeNewswire
Investing.com Canada
Direct company coverage
BriaCell Therapeutics stock plummets after $30 million offering By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jan 2026 08:00
- Source
- Investing.com Canada
Investing.com
Direct company coverage
BriaCell Therapeutics stock plummets after $30 million offering
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jan 2026 08:00
- Source
- Investing.com
Market source
Direct company coverage
Here's Why We're A Bit Worried About BriaCell Therapeutics' (TSE:BCT) Cash Burn Situation
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 25 Jun 2025 07:00
- Source
- Market source
BNN Bloomberg
Direct company coverage
BriaCell Therapeutics Corp (BCT:CT): Stock Price, Quote and News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jan 2025 20:24
- Source
- BNN Bloomberg
Market source
Direct company coverage
Insider Purchases Worth US$5.52m See Losses As BriaCell Therapeutics Market Value Drops To CA$40m
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 19 Dec 2024 08:00
- Source
- Market source
Seeking Alpha
Direct company coverage
BriaCell Therapeutics: High-Potential In Phase 3 Metastatic Breast Cancer, But Financing Concerns
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Oct 2024 07:00
- Source
- Seeking Alpha
Market source
Direct company coverage
Does Market Volatility Impact BriaCell Therapeutics Corp.'s (CVE:BCT) Share Price?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2019 07:00
- Source
- Market source